According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

We reviewed the options for the manufacture and use of DNA microarrays in the original Chipping Forecast 1 in 1999. Since then, the number of companies that produce microarrays equipment and reagents ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...

MtoZ Biolabs provides PhIP-Seq analysis support for antigen epitope screening, antibody repertoire profiling, autoantibody discovery, and biomarker research. BOSTON, MA, UNITED STATES, June 21, 2026 / ...

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

Persistent fatigue, easy bruising, and frequent infections in children might signal inherited blood disorders, not just typical childhood ailments. Early detection through genetic testing is crucial ...

Momentum around the era of genomic medicine is building, and with it, anticipation of the benefits that whole genome analysis (personalized or individualized genomics) will bring for the provision of ...